Tag: Inventiva
Inventiva receives a €4 million milestone payment from AbbVie following the launch of the Phase IIb study with cedirogant – 01/31/2022 at 22:00
Daix (France), Long Island City (New York), United States January 31, 2022 – Inventiva SA (“Inventiva” or the “Company”) (Euronext Paris and Nasdaq: IVA), a biopharmaceutical company specializing in the…
Inventiva announces its participation in several investor conferences in January and February 2022 – 01/20/2022 at 22:00
Daix (France), Long Island City (New York, United States), January 20, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a biopharmaceutical company specializing in the clinical development of small molecules…